The collaboration aims to address gaps in current medical procedures by prioritising simplicity, efficiency, and cost reduction
Sahajanand Medical Technologies (SMT) medical device company in the cardiovascular segment has announced a strategic partnership with HeartX, a medtech company focused on research and development.
Through this collaboration, SMT gains a product line in the Congenital Heart Defect space, broadening its product offerings.
HeartX’s portfolio includes products like the JOVE VB Stent for Sinus Venous ASD, JOVE Versatile ASD (VASO), Fenestrated VASO and JOVE PFO, with ongoing developments in PDA and VSD closures as well as visualisation systems for structural interventions.
SMT’s statement informs that the collaboration aims to address gaps in current medical procedures by prioritising simplicity, efficiency, and cost reduction.
SMT’s CEO Ganesh Sabat further claims, “This strategic partnership greatly expands SMT’s portfolio of medical solutions in the Congenital heart space.”
Adding more on the partnership, the CEO of HeartX, Cheran Uthirapathi says, “This Partnership is aimed at leveraging the core competencies of both HeartX and SMT to deliver solutions that address unmet clinical needs.”
- Advertisement -
